#biolabsinvestorday

BIOLABS

INVESTOR

DAY 2025

SAN DIEGO

October 9th | 1pm-7pm | San Diego

Interest Form

has closed

Thank you for your interest!

Mission

More than ever, great life science startups need extensive investor connections to be successful. That's why BioLabs joins forces with key local ecosystem partners — drawing on our international network of investor relationships — to bring the money and the talent together.

With a successful track record of events in Heidelberg, Germany; Chicago, IL; Princeton, NJ; Philadelphia, PA and Paris, France, San Diego's now-annual Investor Day 2025 will bring together life science investors from across the country and startups from the SoCal region for a day of pre-selected quick pitches and invite-only networking.

Event	Time
Welcome Remarks	1:00 pm
Pitch Block 1	1:15 - 2:45 pm
Coffee Break	2:45 - 3:00 pm
Fireside Chat	3:00 - 3:30 pm
Pitch Block 2	3:30 - 5:00 pm
Reception and Closing Remarks	5:05 - 7:00 pm

Agenda

Meet our Hosts

Gabby Everett

Director of Business Operations & Strategy, Site Head, Biolabs

Gabby is the Director of Business Operations & Strategy and Site Head for BioLabs Pegasus Park, part of the premier national network of shared lab and office facilities supporting high-potential life science startups in key innovation clusters. In this role, she is responsible for recruiting and supporting member companies, cultivating strategic partnerships, and building a thriving biotech ecosystem. Prior to BioLabs, Gabby was the Lead Scientist in the Biotech Group at NCH Corporation, where she led product development efforts from ideation to post commercialization support. She is an inventor on 12 U.S. patents with 8 additional patents pending and was the author or co-author of nearly 50 peer-reviewed publications during her research career. Gabby earned her Ph.D. in Biochemistry from Texas A&M University. She currently serves on the McFerrin Advisory Council and the Therapeutics Advisory Group at Texas A&M, the External Advisory Board of the Biomedical Engineering Department at UT Arlington, and the Product Development Advisory Committee for the Cancer Prevention & Research Institute of Texas (CPRIT). She also contributes to regional biotech strategy, startup advocacy, and science outreach efforts in North Texas.

David H. Crean

Ph.D., MBA
Cardiff Advisory LLC
1004 Venture Partners

David H. Crean is a distinguished executive with over 30 years of experience across the life sciences and healthcare sectors. His career journey is a unique blend of scientific knowledge, business savvy, and financial leadership, which has earned him a reputation as a researcher-turned-dealmaker-turned-venture-capitalist. Dr. Crean currently serves as the Founder and Managing Partner of Cardiff Advisory LLC, an M&A advisory firm, and is a Venture Partner at 1004 Venture Partners, a healthcare investment fund. He has been instrumental in orchestrating more than 50 corporate and business development transactions and has played a key role in the growth of over 100 client companies. Throughout his career, Dr. Crean has held senior leadership roles at prominent companies like Allergan, Inc. (AbbVie), Aqua Pharmaceuticals (Almirall), and Objective Capital Partners. He holds a Ph.D. in Biophysics and an M.S. in Oncology from the State University of New York Buffalo, as well as an MBA in Finance from Pepperdine University. His contributions to the industry have been recognized with multiple awards, including "Advisor of the Year", "Healthcare Hero", and “SD500 Most Influential Business Leaders" by the San Diego Business Journal for the past 5 years.